510(K) CLEARANCES 51 ▲2RECALLS POSTED 25 ▲2CLASS I 1PMA DECISIONS 50 ▲13WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K001118Substantially Equivalent

Modification to Lipoprotein (a) Spq III Antibody Reagent Set

Diasorin Inc., Ellicott City MD / Special, Substantially Equivalent
FDA source (opens on fda.gov)

K001118 is the FDA 510(k) clearance record for MODIFICATION TO LIPOPROTEIN (A) SPQ III ANTIBODY REAGENT SET, a class II device, cleared for DiaSorin, Inc. on under FDA product code DFC (Lipoprotein, Low-Density, Antigen, Antiserum, Control). FDA records list 74 510(k) clearances for DiaSorin, Inc., from to . As of , FDA records show no recalls naming K001118.

Clearance record

Decision date
Received
(18 days to decision)
Product code
DFC Lipoprotein, Low-Density, Antigen, Antiserum, Control
Regulation
21 CFR 866.5600
Device class
Class II
Review panel
Immunology
Applicant
DiaSorin, Inc. 4029 Chariot'S Flight Way, Ellicott City MD
510(k) summary
Summary
Third party review
No

Clearances, product code DFC

Trailing 12 months
1 clearance under product code DFC in the twelve months to November 2026, June 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code DFC, trailing twelve months
MonthClearances
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20261
July 20260
August 20260
September 20260
October 20260
November 20260